Please login to the form below

Not currently logged in
Email:
Password:

ARX-115

This page shows the latest ARX-115 news and features for those working in and with pharma, biotech and healthcare.

AbbVie to develop argenx-partnered GARP-targeted immunotherapy

AbbVie to develop argenx-partnered GARP-targeted immunotherapy

The biotech can also co-promote ARGX-115-based products in the EU and Swiss Economic Area if it wishes. ... β). The companies have said that ARGX-115 will selectively limit the activity of activated regulatory T-cells (Tregs).

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics